Amrita Ghose

1 presentation

• W8. SAFETY AND TOLERABILITY OF 32-WEEK-LONG TREATMENT WITH TIRZEPATIDE IN INDIVIDUALS WITH MODERATE-TO-SEVERE METHAMPHETAMINE USE DISORDER

  2026 ASCP Annual Meeting